-
-
-
-
-
-
-
Soligenix halts phase 3 trial of HyBryte for lymphoma treatment
-
-
-
-
-
-
-
Soligenix Announces Recent Accomplishments And Second Quarter 2025 Financial Results
-
-
-
-
-
-
-
Soligenix and Sharps Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
-
-
-
-
-
-
Soligenix Enters into Exclusive Option Agreement with Silk Road Therapeutics for Rights to Topical Pentoxifylline Designed to Treat Behçet's Disease
-
-
-
-
-
-
-
Celularity Appoints Industry Leader Diane Parks to its Board of Directors
-
-
-
-
-
-
-
Pre-Open Stock Movers 12/22: (JG) (AMTX) (SPWH) (CLA) (MDCA) (QS) (more...)
-
-
-
-
-
-
-
Soligenix Announces Recent Accomplishments and Year-End 2014 Financial Results
1,180,361 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

